Association between dyslipidemia and CCL2 in patients undergoing hemodialysis-Reference-Cited by-同舟云学术

Association between dyslipidemia and CCL2 in patients undergoing hemodialysis

Published:2020-01 Issue: Volume:125 Page:154858
ISSN:1043-4666
Container-title:Cytokine
language:en
Short-container-title:Cytokine

Author:

de Oliveira Junior Wander Valadares,Silva Ana Paula Ferreira,de Figueiredo Roberta Carvalho,Gomes Karina Braga,Simões e Silva Ana Cristina,Dusse Luci Maria Sant'Ana,Rios Danyelle Romana Alves

Funder

CNPq

Publisher

Elsevier BV

Subject

Molecular Biology,Hematology,Biochemistry,Immunology,Immunology and Allergy

Reference48 articles.

1. Atualização da diretriz brasileira de dislipidemias e prevenção da aterosclerose–2017;Faludi;Arq. Bras. Cardiol.,2017

2. Accelerated atherosclerosis in prolonged maintenance hemodialysis;Lindner;N. Engl. J. Med.,1974

3. Cytokine signature in end-stage renal disease patients on hemodialysis;Rios;Dis. Markers,2017

4. Disorders of lipid metabolism in chronic kidney disease;Bulbul;Blood Purif.,2018

5. Microinflammation is involved in the dysfunction of arteriovenous fistula in patients with maintenance hemodialysis;Liu;Chin Med J (Engl),2008

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced glycosylation end products as metabolic predictors of systemic pro-inflammatory and prooxidant status in patients with end-stage renal disease;Cytokine;2023-06

2. Characteristics and pathogenesis of chemokines in the post-stroke stage;International Immunopharmacology;2023-03

3. Cytokines and chemokines systemic levels are related to dialysis adequacy and creatinine clearance in patients with end-stage renal disease undergoing hemodialysis;International Immunopharmacology;2021-11

4. Review on Inflammation Markers in Chronic Kidney Disease;Biomedicines;2021-02-11